Thus, our results suggest that the QC-induced activation of JNK1 contributes to Nrf2 degradation in QC-treated CRC cells by promoting the interaction between Keap1 and Nrf2 (Figure 4). The gene discussed is NFE2L2; the disease is colorectal carcinoma.